ISLAMABAD: The Chief Executive Officer (CEO) of DRAP (Drug Regulatory Authority of Pakistan) has taken the initiative to urgently conduct a comprehensive survey of the pharmaceutical market throughout the nation.
As per the provided information, the Drug Regulatory Authority of Pakistan (DRAP) has finalized significant measures to ensure the availability of essential life-saving medications. The CEO of DRAP has directed for a comprehensive report outlining the current status of available drugs within the country’s pharmaceutical market.
As per the communication forwarded to the respective provincial offices under the directives of CEO Dr. Asim Raouf, the provincial branches of DRAP have been tasked with conducting an extensive survey of the pharmaceutical market across the country.
The communication emphasized that the provincial offices are required to present the survey findings regarding the pharmaceutical market within a span of three days. Additionally, the CEO of DRAP has also issued directives to enhance the monitoring of the pharmaceutical markets across the nation.
Dr. Asim Rauf of DRAP highlighted that reports of scarcities of life-saving medications have been lodged from various cities. Ensuring the accessibility of essential life-saving drugs within the country stands as the utmost concern, prompting the utilization of all available resources for this purpose.
The CEO of DRAP emphasized ongoing collaborations with manufacturers and importers to secure a consistent supply of medicines. The primary objective remains ensuring the availability of medicines that are not only of high quality but also affordable and safe for the populace.
As indicated in the communication, certain vested interests often manipulate the market to create artificial shortages of medicines. DRAP is actively taking measures against such disruptive forces to ensure the steady availability of medications.
In a separate interview with khabristan News, CEO Dr. Asim Rauf reiterated that numerous individuals responsible for orchestrating artificial shortages of medicines have been apprehended. Stringent actions are inevitable against those who engage in hoarding essential medications.
Dr. Asim Raouf emphasized that measures have been implemented to address the issue of selling drugs at inflated prices. The oversight of the national pharmaceutical market is being intensified, aiming to bolster stringent monitoring. Those involved in creating artificial scarcities of medications will be identified through enhanced surveillance methods.
Leave a Comment